Service de médecine physique et réadaptation, hôpital d'instruction des armées Laveran, Marseille cedex 13, France.
Ann Phys Rehabil Med. 2010 Nov;53(9):575-83. doi: 10.1016/j.rehab.2010.08.029. Epub 2010 Sep 21.
We report the case of a patient who developed paraplegia following a low lumbar epidural steroid injection. Alternative approaches to (or alternative means of) performing transforaminal injections should be considered, in order to avoid devastating neurological complications.
A 54-year-old man (who had undergone surgery 14 years earlier to cure an L5-S1 slipped disc with right S1 radiculopathy) presented with low back pain (which had begun 6 weeks previously) and left S1 radiculopathy. During a second infiltration of prednisolone acetate, the patient reported feeling a heat sensation in his legs and concomitantly developed facial flushing. Immediately after the injection, the patient developed complete, flaccid T7 ASIA A motor and sensory paraplegia. Three days later, T2 magnetic resonance imaging (MRI) of the spine revealed a spontaneous hypersignal in the conus medullaris and from T6 to T9, suggesting medullary ischemia. Recovery has been slow; after 4 months of treatment in a physical and rehabilitation medicine department, urinary and sensory disorders are still present (T7 ASIA D paraplegia). The patient can walk 200 m unaided. Three months later, the MRI data had not changed.
This is a rare case report of paraplegia following low lumbar epidural infiltration via an interlaminar route. The mechanism is not clear. Most of authors suggest that the pathophysiological basis of this type of complication is ischemia caused by accidental interruption of the medullary blood supply. Direct damage to a medullary artery, arterial spasm or corticosteroid-induced occlusion due to undetected intra-arterial injection could result in medullary infarction. This serious incident should prompt us to consider how to avoid further problems in the future. It also raises the issue of providing patients with information on the risks inherent in this type of procedure.
Despite the rarity of this complication, patients should be made aware of its potential occurrence. In the case reported here, the functional prognosis is uncertain.
我们报告了一例因低位腰椎硬膜外类固醇注射而导致截瘫的患者。为了避免毁灭性的神经并发症,应考虑采用替代的(或其他的)经椎间孔注射方法。
一名 54 岁男性(14 年前曾因 L5-S1 椎间盘突出症合并右侧 S1 神经根病而行手术治疗),出现腰痛(始于 6 周前)和左侧 S1 神经根病。在第二次醋酸泼尼松龙浸润时,患者自述腿部有发热感,同时出现面部潮红。注射后即刻,患者出现完全性弛缓性 T7 ASIA A 运动和感觉性截瘫。3 天后,脊柱 T2 磁共振成像(MRI)显示圆锥内自发性高信号,从 T6 到 T9,提示髓内缺血。恢复缓慢;在物理和康复医学科治疗 4 个月后,仍存在尿便障碍(T7 ASIA D 截瘫)。患者可独立行走 200 米。3 个月后,MRI 数据无变化。
这是一例罕见的低位腰椎经椎间孔硬膜外渗透导致截瘫的病例报告。其机制尚不清楚。大多数作者认为,这种并发症的病理生理基础是意外中断脊髓血供引起的缺血。由于未检测到动脉内注射,直接损伤脊髓动脉、动脉痉挛或皮质类固醇引起的闭塞可能导致脊髓梗死。这一严重事件应促使我们思考如何避免未来出现更多问题。它还提出了向患者提供此类手术固有风险信息的问题。
尽管这种并发症罕见,但应让患者意识到其潜在发生的可能性。在本例报告中,功能预后不确定。